XML 29 R21.htm IDEA: XBRL DOCUMENT
v3.19.2

Financial Instruments (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2019
Financial Instruments |
Schedule of Contingent consideration |
|  | Diabetes |  |  |  |  |  |
|  | Alliance |  | Other |  | Total |  | Total
|  | 2019 |  | 2019 |  | 2019 |  | 2018
|  | $m |  | $m |  | $m |  | $m
At 1 January |  | 3,983 |  | 1,123 |  | 5,106 |  | 5,534
Settlements |  | (225) |  | (143) |  | (368) |  | (151)
Revaluations |  | - |  | - |  | - |  | 38
Discount unwind |  | 144 |  | 35 |  | 179 |  | 208
At 30 June |  | 3,902 |  | 1,015 |  | 4,917 |  | 5,629

X
- Definition The disclosure of contingent liabilities in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2018-01-01 -Paragraph B64 -Subparagraph j -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2018-03-01&anchor=para_B64_j&doctype=Appendix&seq=2 -URIDate 2018-03-16 + Details
Name: | ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration